The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16434675.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
During the first 6 months of glatiramer acetate therapy in 82 consecutive patients with multiple sclerosis, in only 6% frequency of pre-existing headaches increased by more than 50%. This is less than the headache aggravation reported in an earlier study in up to 35% of patients during the first 6 months on interferon beta.
Medical subject headings
- Headache
- Immunosuppressive Agents
- Multiple Sclerosis
- Peptides